GURUFOCUS.COM » STOCK LIST » USA » NYSE » Organon & Co (NYSE:OGN) » Definitions » Profitability Rank
Switch to:

Organon Profitability Rank

: 5 (As of Jun. 2022)
View and export this data going back to 2021. Start your Free Trial

Organon has the Profitability Rank of 5.

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way. It is based on these factors:

1. Operating Margin %
2. Piotroski F-Score
3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.
4. Consistency of the profitability
5. Predictability Rank

Organon's Operating Margin % for the quarter that ended in Jun. 2022 was 29.53%. As of today, Organon's Piotroski F-Score is 9999.


Competitive Comparison

For the Drug Manufacturers - General subindustry, Organon's Profitability Rank, along with its competitors' market caps and Profitability Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

   

Organon Profitability Rank Distribution

For the Drug Manufacturers industry and Healthcare sector, Organon's Profitability Rank distribution charts can be found below:

* The bar in red indicates where Organon's Profitability Rank falls into.



Organon Profitability Rank Calculation

GuruFocus Profitability Rank ranks how profitable a company is and how likely the company's business will stay that way.

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Organon has the Profitability Rank of 5.

Profitability Rank is not directly related to the Financial Strength. But if a company is consistently profitable, its financial strength will be stronger.

Profitability Rank is based on these factors:

1. Operating Margin %

Operating Margin % - also known as operating income margin, operating profit margin and return on sales (ROS) - is the ratio of Operating Income divided by net sales or Revenue, usually presented in percent.

Organon's Operating Margin % for the quarter that ended in Jun. 2022 is calculated as:

Operating Margin %=Operating Income (Q: Jun. 2022 ) / Revenue (Q: Jun. 2022 )
=468 / 1585
=29.53 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

2. Piotroski F-Score

The zones of discrimination were as such:

Good or high score = 8 or 9
Bad or low score = 0 or 1

Organon has an F-score of 9999. It is a bad or low score, which usually implies poor business operation.

3. Trend of the Operating Margin % (5-year average). The company with an uptrend profit margin has a higher rank.

4. Consistency of the profitability

5. Predictability Rank


Organon Profitability Rank Related Terms

Thank you for viewing the detailed overview of Organon's Profitability Rank provided by GuruFocus.com. Please click on the following links to see related term pages.


Organon Business Description

Organon logo
Traded in Other Exchanges
Address
30 Hudson Street, Floor 33, Jersey City, NJ, USA, 07302
Organon & Co is a science-based global pharmaceutical company that develops and delivers health solutions through a portfolio of prescription therapies within women's health, biosimilars, and established brands. Geographically, it derives a majority of revenue from Europe and Canada.
Executives
Whiteford Grace Puma director C/O WILLIAM SONOMA, INC. 3250 VAN NESS AVENUE SAN FRANCISCO CA 94109
Nisita Vittorio officer: Head of Global Business Svcs 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Morrissey Joseph T. Jr. officer: Head of Manufacturing 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Falcione Aaron officer: Chief Human Resources Officer 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Leone Deborah R director 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Mcgarry Martha E director 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Ozuah Phillip director 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Ritter Geralyn S officer: Hd of Ext. Affairs and ESG 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Milligan Sandra officer: Head of Research & Development 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Telman Deborah H officer: General Counsel 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Fiedler Susanne officer: Chief Commercial Officer 2000 GALLOPING HILL ROAD KENILWORTH NJ 07033
Ezekowitz Alan director C/O FULCRUM THERAPEUTICS, INC. 26 LANDSDOWNE STREET CAMBRIDGE MA 02139
Stahler Rachel A officer: Chief Information Officer 12701 COMMONWEALTH DRIVE SUITE 9 FORT MYERS FL 33913
Essner Robert director
Dimarco Kathryn officer: Corporate Controller 30 HUDSON STREET, FLOOR 33 JERSEY CITY NJ 07302

Organon Headlines

Other Sources

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)